- Home
- TIL vs RTB Comparison
TIL vs RTB Comparison
Compare TIL & RTB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | TIL | RTB |
|---|---|---|
| Founded | 2018 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Professional Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 52.2M | 59.2M |
| IPO Year | 2021 | 2008 |
Fundamental Metrics
Financial Performance| Metric | TIL | RTB |
|---|---|---|
| Price | $7.58 | $11.44 |
| Analyst Decision | Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $125.00 | N/A |
| AVG Volume (30 Days) | 5.8K | ★ 47.0K |
| Earning Date | 05-08-2026 | N/A |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 6.06 | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $11,131,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $5.67 | $10.14 |
| 52 Week High | $30.50 | $20.75 |
Technical Indicators
Market Signals| Indicator | TIL | RTB |
|---|---|---|
| Relative Strength Index (RSI) | 51.76 | 37.30 |
| Support Level | $7.43 | N/A |
| Resistance Level | $7.99 | $19.61 |
| Average True Range (ATR) | 0.22 | 1.79 |
| MACD | 0.01 | -0.26 |
| Stochastic Oscillator | 48.21 | 17.55 |
Price Performance
Historical ComparisonAbout TIL Instil Bio Inc.
Instil Bio Inc is a clinical-stage biopharmaceutical company focused on developing a cell therapy pipeline of autologous tumor infiltrating lymphocyte, or TIL, therapies for the treatment of patients with cancer. It is also engaged in developing a novel class of genetically engineered TIL therapies using its Co-Stimulatory Antigen Receptor, or CoStAR, platform. Its pipeline includes ITIL-306 which expresses a CoStAR molecule designed to recognize, a tumor-associated antigen that is expressed on numerous solid tumors, including ovarian cancer, uterine cancer, NSCLC, and renal cancer.
About RTB RTB Digital Inc. Common Stock
RTB Digital Inc is focused on developing and operating a professional SaaS (Software as a Service) platform which hosts an exclusive coalition of professionally-managed online media channels. Its operations include software development, advertising and sponsorship sales, and onboarding third-party content operators (Platform Partners) to publish content on the platform.